Brief: Tenaya Therapeutics Inc Believes Its Exposure To Loss Due To Svb’S Receivership To Be Immaterial
13/03/2023 11:49
March 13 (Reuters) - Tenaya Therapeutics Inc TNYA.O :
* TENAYA THERAPEUTICS INC - MAINTAINS OPERATING ACCOUNTS AT
SVB
WITH MINIMAL BALANCE COMPARED TO CO'S TOTAL CASH, EQUIVALENTS,
INVESTMENTS IN MARKETABLE SECURITIES
* TENAYA THERAPEUTICS INC - BELIEVES ITS EXPOSURE TO LOSS AS
A
RESULT OF SVB’S RECEIVERSHIP TO BE IMMATERIAL
Source text : (https://bit.ly/3yv1rNL)
Further company coverage: TNYA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tenaya Therapeutics
See all newsBrief: Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment Of Mybpc3-Associated Hcm With TN-201 Gene Therapy Resulted In Consistent Signs Of Cardiac Remodeling And Reductions In Symptoms
Brief: Positive Interim Data From Cohorts 1 And 2 Of Tenaya's Ridge-1 Phase 1B/2 Clinical Trial Of TN-401
Tenaya Therapeutics Q1 net loss widens, misses analyst expectations
Brief: Tenaya Therapeutics Q1 Net Income USD -19.272 Million
Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027